// App-Quantinova.ai

Mo1479 : Serum Alpha Fetoprotein in Hepatocellular Carcinoma: Effect of Etiology, Race, and Severity of Liver Inflammation

Researchers

Presenter

  • Jianliang Dai

Principal Investigators

  • Benyam D. Addissie

  • Lewis R. Roberts

  • Mindie H. Nguyen

  • Alex Befeler

  • K R. Reddy

  • Myron Schwartz

  • Denise M. Harnois

  • Gregory J. Gores

  • Ziding Feng

  • Jorge Marrero

Medical Centers

  • Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

  • Gastroenterology and Hepatology, College of Medicine, Mayo Clinic, Jacksonville, Florida, United States

  • Washington University, St. Louis, Missouri, United States

  • Montefiore Medical Center, Medicine, New York, United States

  • Stanford Medical Center, Palo Alto, California, United States

  • University of Pennsylvania, Philadelphia, Pennsylvania, United States

  • UT Southwestern Medical Center, Dallas, Texas, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Cirrhosis

  • Solid malignancies

Biomarkers

  • Alanine transaminase

  • Alpha-fetoprotein

Drug/Treatment

  • N/A

Outcome

  • Unknown


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim